Peptide aptamers: Powerful new tools for molecular medicine

Journal of Molecular Medicine

Volumn 78, Issue 8, 2000, Pages 426-430

  Hoppe Seyler, Felix ^a   Butz, Karin ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Drug design; Peptides; Protein function; Protein therapy; Yeast two hybrid

Indexed keywords

APTAMER; HYBRID PROTEIN; PEPTIDE FRAGMENT; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANTIMICROBIAL ACTIVITY; BACTERIAL VIRULENCE; BINDING AFFINITY; BINDING SITE; DIAGNOSTIC VALUE; DNA BINDING; DRUG DESIGN; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG TARGETING; GENE FUNCTION; GENE TARGETING; GENE THERAPY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; REVIEW; YEAST;

EID: 0033762032     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001090000140     Document Type: Review

References (25)

1. The selection of intracellular antibodies
2. The two-hybrid system: An assay for protein-protein interactions
3. Protein-protein interactions: Methods for detection and analysis
4. Selection of antibodies for intracellular function using a two-hybrid in vivo system
5. Protein-peptide interactions analyzed with the yeast two-hybrid system
6. Genetic selection of peptide aptamers that recognize and inhibit cyclin-dependent kinase 2
7. Constrained peptides as binding entities
8. Genetic selection of peptide inhibitors of biological pathways
9. An artificial cell-cycle inhibitor isolated from a combinatorial library
10. Tendamistat as a scaffold for conformationally constrained phage peptide libraries
11. Selection of peptides that functionally replace a zinc finger in the Sp1 transcription factor by using a yeast combinatorial library
12. Green fluorescent protein as a scaffold for intracellular presentation of peptides
13. Transdominant genetic analysis of a growth control pathway
14. Targeting cyclin-dependent kinases in Drosophila with peptide aptamers
15. Inhibition of mammalian cell proliferation by genetically selected peptide aptamers that functionally antagonize E2F activity
16. Induction of apoptosis in human papillomavirus-positive cancer cells by peptide aptamers targeting the viral E6 oncoprotein
17. Isolation of peptide aptamers that inhibit intracellular processes
18. 'Mutagenesis' by peptide aptamers identifies genetic network members and pathway connections
19. Minimized proteins
20. Drug delivery and targeting
21. Improving protein therapeutics with sustained-release formulations
22. In vivo protein transduction: Intracellular delivery of biologically active proteins, compounds and DNA
23. Therapeutic peptides revisited
24. Recent developments in structural-based drug design
25. Protease inhibitors: Current status and future prospects